Details of the Drug
General Information of Drug (ID: DM37T5L)
Drug Name |
5-bromo-N-(quinolin-8-yl)thiophene-2-sulfonamide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
5-bromo-N-quinolin-8-ylthiophene-2-sulfonamide; 5-bromo-N-(quinolin-8-yl)thiophene-2-sulfonamide; 620103-87-9; CHEMBL401504; AC1M3N93; SCHEMBL11995751; CTK5I7875; MolPort-000-693-109; ZINC2888883; ALBB-010070; STK506180; BDBM50372503; BBL018066; AKOS001440266; MCULE-3903306629; NCGC00161700-01; TR-061560; TR-039409; R9130; 2-Thiophenesulfonamide, 5-bromo-N-8-quinolinyl-
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 369.3 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||